ACELYRIN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.73 USD | +0.85% |
|
+2.38% | -36.60% |
| 05-09 | Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024 | CI |
| 05-09 | Acelyrin, Inc. Announces CEO Changes | CI |
Chart calendar Acelyrin, Inc.
5d0dd23.Ro_Y2Z2dXwMLKeb7UViL7-UVOD3UYdDspjBi3CiUUdo.ccy6ts6tC2tsHIKhADHatb1ReVO8M5-ix1o95VHcJbUt5YmG0PsdbFp-vw~149ebad189e575212898507877414b65
Upcoming events on Acelyrin, Inc.
Past events on Acelyrin, Inc.
| 13/05/2024 21:30 | Q1 2024 Earnings Call |
| 12/05/2024 | Q1 2024 Earnings Release |
| 28/03/2024 20:05 | Q4 2023 Earnings Release |
| 20/03/2024 12:30 | Lonigutamab Phase 1/2 Proof of concept Data in Thyroid Eye Disease Call |
| 10/03/2024 | Investor Meeting |
| 14/02/2024 | Investor Meeting |
| 16/11/2023 09:00 | Jefferies London Healthcare Conference |
| 07/11/2023 21:30 | Q3 2023 Earnings Call |
| 07/11/2023 21:05 | Q3 2023 Earnings Release |
| 13/09/2023 16:30 | Morgan Stanley Global Healthcare Conference |
| 11/09/2023 22:30 | Izokibep Phase 2b/3 Trial Results Call |
| 14/08/2023 21:30 | Q2 2023 Earnings Call |
| 14/08/2023 21:05 | Q2 2023 Earnings Release |
| 15/06/2023 21:05 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 -416 - | -416 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -422 -418 -0.93% | -423 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -382 -386 1.23% | -412 |
|
Net income Million USD | Released Forecast Spread | -64,8 | -382 -386 1.23% | -412 |
|
EPS USD | Released Forecast Spread | -21,1 | -5,43 -7,14 23.92% | -4,25 |
| Announcement Date | 13/04/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -99,1 | -101 | -103 | -105 | |||||
|
EBIT Million USD | Released Forecast Spread | -42,7 -59,8 28.64% | -94,4 -46,1 -104.82% | -105 -99,3 -5.9% | -99,8 | -104 | -110 | -118 | -170 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,0 -60,7 57.13% | -83,9 -41,7 -101.42% | -95,2 -95,0 -0.2% | -95,0 | -99,7 | -108 | -119 | -170 | |
|
Net income Million USD | Released Forecast Spread | -176 | -26,0 -60,7 57.13% | -83,9 -41,7 -101.42% | -95,2 -95,0 -0.2% | -95,0 | -99,7 | -108 | -119 | -170 |
|
EPS USD | Released Forecast Spread | -8,61 | -0,40 -0,85 52.66% | -0,87 -0,47 -86.7% | -0,75 -0,99 23.93% | -0,98 | -1,03 | -1,11 | -1,24 | -1,69 |
| Announcement Date | 15/06/23 | 14/08/23 | 07/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for Acelyrin, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLRN Stock
- Calendar Acelyrin, Inc.
